Company
Headquarters: Riverside, CA, United States
CEO: Mr. David S. Hanson
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Ingen Technologies, Inc., a medical device manufacturing company, manufactures medical products for the respiratory industry in United States. The company manufactures medical equipment for patients suffering with chronic obstructive pulmonary disease; and oxygen flow meters and nasal cannulas under the Oxyview and Smart Nasal Cannula trademark name. Its Oxyview is a pneumatic metering device that displays and confirms the oxygen flow rate near the patient. Ingen Technologies, Inc. was founded in 1999 and is based in Riverside, California.
Ingen Technologies, Inc. has the following listings and related stock indices.
Stock: OTC: IGNT wb_incandescent